Atrioventricular conduction in patients undergoing pacemaker implant following self‐expandable transcatheter aortic valve replacement
dc.contributor.author | Ghannam, Michael | |
dc.contributor.author | Cunnane, Ryan | |
dc.contributor.author | Menees, Daniel | |
dc.contributor.author | Grossman, Michael P. | |
dc.contributor.author | Chetcuti, Stanley | |
dc.contributor.author | Patel, Himanshu | |
dc.contributor.author | Deeb, Michael | |
dc.contributor.author | Jongnarangsin, Krit | |
dc.contributor.author | Pelosi, Frank | |
dc.contributor.author | Oral, Hakan | |
dc.contributor.author | Latchamsetty, Rakesh | |
dc.date.accessioned | 2019-08-09T17:12:34Z | |
dc.date.available | WITHHELD_12_MONTHS | |
dc.date.available | 2019-08-09T17:12:34Z | |
dc.date.issued | 2019-07 | |
dc.identifier.citation | Ghannam, Michael; Cunnane, Ryan; Menees, Daniel; Grossman, Michael P.; Chetcuti, Stanley; Patel, Himanshu; Deeb, Michael; Jongnarangsin, Krit; Pelosi, Frank; Oral, Hakan; Latchamsetty, Rakesh (2019). "Atrioventricular conduction in patients undergoing pacemaker implant following self‐expandable transcatheter aortic valve replacement." Pacing and Clinical Electrophysiology 42(7): 980-988. | |
dc.identifier.issn | 0147-8389 | |
dc.identifier.issn | 1540-8159 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/150495 | |
dc.description.abstract | BackgroundHeart block requiring a pacemaker is common after self‐expandable transcatheter aortic valve replacement (SE‐TAVR); however, conduction abnormalities may improve over time. Optimal device management in these patients is unknown.ObjectiveTo evaluate the long‐term, natural history of conduction disturbances in patients undergoing pacemaker implantation following SE‐TAVR.MethodsAll patients who underwent new cardiac implantable electronic device (CIED) implantation at Michigan Medicine following SE‐TAVR placement between January 1, 2012 and September 25, 2017 were identified. Electrocardiogram and device interrogation data were examined during follow‐up to identify patients with recovery of conduction. Logistic regression analysis was used to compare clinical and procedural variables to predict conduction recovery.ResultsFollowing SE‐TAVR, 17.5% of patients underwent device placement for new atrioventricular (AV) block. Among 40 patients with an average follow‐up time of 17.1 ± 8.1 months, 20 (50%) patients had durable recovery of AV conduction. Among 20 patients without long‐term recovery, four (20%) had transient recovery. The time to transient conduction recovery was 2.2 ± 0.2 months with repeat loss of conduction at 8.2 ± 0.9 months. On multivariate analysis, larger aortic annular size (odds ratio: 0.53 [0.28–0.86]/mm, P = 0.02) predicted lack of conduction recovery.ConclusionsHalf of the patients undergoing CIED placement for heart block following SE‐TAVR recovered AV conduction within several months and maintained this over an extended follow‐up period. Some patients demonstrated transient recovery of conduction before recurrence of conduction loss. Larger aortic annulus diameter was negatively associated with conduction recovery. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | atrioventricular block | |
dc.subject.other | conduction recovery | |
dc.subject.other | device therapy | |
dc.subject.other | pacemaker | |
dc.subject.other | transcutaneous aortic valve replacement | |
dc.title | Atrioventricular conduction in patients undergoing pacemaker implant following self‐expandable transcatheter aortic valve replacement | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Physiology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/150495/1/pace13694_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/150495/2/pace13694.pdf | |
dc.identifier.doi | 10.1111/pace.13694 | |
dc.identifier.source | Pacing and Clinical Electrophysiology | |
dc.identifier.citedreference | Wilczek K, Regula R, Bujak K, Chodor P, Dlugaszek M, Gasior M. Conduction disturbances after transcatheter aortic valve implantation procedures ‐ predictors and management. Postepy Kardiol Interwencyjnej. 2016; 12: 203 ‐ 211. | |
dc.identifier.citedreference | Nishimura R, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63: e57 ‐ 185. | |
dc.identifier.citedreference | Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008; 1: 310 ‐ 316. | |
dc.identifier.citedreference | Guetta V, Goldenberg G, Segev A, et al. Predictors and course of high‐degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve revalving system. Am J Cardiol. 2011; 108: 1600 ‐ 1605. | |
dc.identifier.citedreference | van der Boon RM, Van Mieghem NM, Theuns DA, et al. Pacemaker dependency after transcatheter aortic valve implantation with the self‐expanding Medtronic CoreValve system. Int J Cardiol. 2013; 168: 1269 ‐ 1273. | |
dc.identifier.citedreference | Goldenberg G, Kusniec J, Kadmon E, et al. Pacemaker implantation after transcatheter aortic valve implantation. Am J Cardiol. 2013; 112: 1632 ‐ 1634. | |
dc.identifier.citedreference | Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: Impact on late clinical outcomes and left ventricular function. Circulation. 2014; 129: 1233 ‐ 1243. | |
dc.identifier.citedreference | Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: The PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015; 8: 60 ‐ 69. | |
dc.identifier.citedreference | Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans‐catheter aortic valve implantation: What is the incidence and are there any predicting factors ? Interactive Cardiovasc Thoracic Surg. 2011; 12: 243 ‐ 253. | |
dc.identifier.citedreference | Abdel‐Wahab M, Neumann FJ, Mehilli J, et al. 1‐year outcomes after transcatheter aortic valve replacement with balloon‐expandable versus self‐expandable valves: Results from the CHOICE randomized clinical trial. J Am Coll Cardiol. 2015; 66: 791 ‐ 800. | |
dc.identifier.citedreference | Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2012; 6: 366 ‐ 380. | |
dc.identifier.citedreference | Dvir D, Webb JG, Piazza N, et al. Multicenter evaluation of transcatheter aortic valve replacement using either Sapien Xt or CoreValve: Degree of device oversizing by computed‐tomography and clinical outcomes. Catheter Cardiovasc Interv. 2015; 86: 508 ‐ 515. | |
dc.identifier.citedreference | Maeno Y, Abramowitz Y, Yoon SH, et al. Transcatheter aortic valve replacement with different valve types in elliptic aortic annuli. Circ J. 2017; 81: 1036 ‐ 1042. | |
dc.identifier.citedreference | Holmes DR Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: From the STS/ACC TVT Registry. J Am Coll Cardiol. 2015; 66: 2813 ‐ 2823. | |
dc.identifier.citedreference | Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: Analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016; 9: 2189 ‐ 2199. | |
dc.identifier.citedreference | Di Carlo D. A mechanical biomarker of cell state in medicine. J Lab Autom. 2012; 17: 32 ‐ 42. | |
dc.identifier.citedreference | Young Lee M, Chilakamarri Yeshwant S, Chava S, Lawrence Lustgarten D. Mechanisms of heart block after transcatheter aortic valve replacement ‐ cardiac anatomy, clinical predictors and mechanical factors that contribute to permanent pacemaker implantation. Arrhythm Electrophysiol Rev. 2015; 4: 81 ‐ 85. | |
dc.identifier.citedreference | Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv. 2008; 1: 305 ‐ 309. | |
dc.identifier.citedreference | Moreno R, Dobarro D, Lopez de Sa E, et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: Insights from a necropsy study. Circulation. 2009; 120: e29 ‐ 30. | |
dc.identifier.citedreference | MacDonald I, Pasupati S. Transcatheter aortic valve implantation: Know the differences between the currently available technologies. Eur Heart J. 2010; 31: 1663 ‐ 1665. | |
dc.identifier.citedreference | Brignole M, Auricchio A, Baron‐Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013; 34: 2281 ‐ 2329. | |
dc.identifier.citedreference | Roten L, Wenaweser P, Delacretaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010; 106: 1473 ‐ 1480. | |
dc.identifier.citedreference | Raelson CA, Gabriels J, Ruan J, et al. Recovery of atrioventricular conduction in patients with heart block after transcatheter aortic valve replacement. J Cardiovasc Electrophysiol. 2017; 28: 1196 ‐ 1202. | |
dc.identifier.citedreference | Gaede L, Kim WK, Liebetrau C, et al. Pacemaker implantation after TAVI: Predictors of AV block persistence. Clin Res Cardiol. 2018; 107: 60 ‐ 69. | |
dc.identifier.citedreference | Kaplan RM, Yadlapati A, Cantey EP, et al. Conduction recovery following pacemaker implantation after transcatheter aortic valve replacement. Pacing Clin Electrophysiol. 2019; 42: 146 ‐ 152. | |
dc.identifier.citedreference | Baraki H, Al Ahmad A, Jeng‐Singh S, et al. Pacemaker dependency after isolated aortic valve replacement: Do conductance disorders recover over time. Interact Cardiovasc Thorac Surg. 2013; 16: 476 ‐ 481. | |
dc.identifier.citedreference | Jankelson L, Bordachar P, Strik M, Ploux S, Chinitz L. Reducing right ventricular pacing burden: Algorithms, benefits, and risks. Europace. 2019; 21: 539 ‐ 547. | |
dc.identifier.citedreference | Kusumoto FM, Schoenfeld MH, Barrett C, et al. ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. Circulation. 2018; 2018:CIR0000000000000628. | |
dc.identifier.citedreference | Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70: 252 ‐ 289. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.